Biolife Solutions (BLFS) Current Deferred Revenue (2010 - 2023)
Biolife Solutions (BLFS) reported Current Deferred Revenue of $422000.0 for Q1 2023, down 52.85% year-over-year from $895000.0 in Q1 2022, and down 22.99% on a QoQ basis from $548000.0 in Q4 2022.
Biolife Solutions (BLFS) has 14 years of Current Deferred Revenue data on file, last reported at $422000.0 in Q1 2023.
- Quarterly Current Deferred Revenue fell 52.85% year-over-year to $422000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $422000.0 (down 52.85% YoY) and the FY2022 annual result came in at $548000.0, down 32.68% from the prior year.
- Current Deferred Revenue retreated to $422000.0 in Q1 2023 per BLFS's latest filing, from $548000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $944000.0 in Q2 2021 and bottomed at $324000.0 in Q4 2019.
- The 5-year median for Current Deferred Revenue is $662000.0 (2021), against an average of $646363.6.
- The widest annual swing landed in 2020, when Current Deferred Revenue jumped 187.35%; it then sank 54.34% in 2022.
- Tracing BLFS's Current Deferred Revenue over 5 years: stood at $324000.0 in 2019, then jumped by 187.35% to $931000.0 in 2020, then decreased by 12.57% to $814000.0 in 2021, then plunged by 32.68% to $548000.0 in 2022, then decreased by 22.99% to $422000.0 in 2023.
- Per Business Quant, the three latest BLFS Current Deferred Revenue figures stand at $422000.0 (Q1 2023), $548000.0 (Q4 2022), and $429000.0 (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 429,000.00 |
| Jun 30, 2022 | 431,000.00 |
| Mar 31, 2022 | 895,000.00 |
| Dec 31, 2021 | 814,000.00 |
| Sep 30, 2021 | 710,000.00 |
| Jun 30, 2021 | 944,000.00 |
| Mar 31, 2021 | 662,000.00 |
| Dec 31, 2020 | 931,000.00 |
| Dec 31, 2019 | 324,000.00 |
| Dec 31, 2018 | 130,000.00 |
| Sep 30, 2018 | 130,216.00 |
| Jun 30, 2018 | 130,216.00 |
| Dec 31, 2017 | 130,000.00 |
| Sep 30, 2017 | 130,216.00 |
| Jun 30, 2017 | 130,216.00 |
| Mar 31, 2017 | 130,216.00 |
| Dec 31, 2016 | 130,216.00 |
| Sep 30, 2016 | 130,216.00 |
| Jun 30, 2016 | 130,216.00 |
| Dec 31, 2015 | 130,216.00 |
| Sep 30, 2015 | 130,216.00 |
| Mar 31, 2015 | 130,216.00 |
| Dec 31, 2014 | 130,216.00 |
| Mar 31, 2014 | 958,231.00 |
| Dec 31, 2013 | 1.00 Mn |
| Jun 30, 2013 | 109,167.00 |
| Mar 31, 2013 | 109,167.00 |
| Dec 31, 2012 | 950,079.00 |
| Sep 30, 2012 | 20,000.00 |
| Jun 30, 2012 | 178,717.00 |
| Mar 31, 2012 | 20,000.00 |
| Dec 31, 2011 | 20,000.00 |
| Sep 30, 2011 | 20,000.00 |
| Jun 30, 2011 | 20,000.00 |
| Dec 31, 2010 | 20,000.00 |